EA
ZBH icon

Euclid Advisors’s Zimmer Biomet ZBH Stock Holding History

Euclid Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-13,519
Closed -$1.58M – 474
2016
Q2 		$1.58M Buy
13,519
+1,525
+13% +$173K 0.07% 298
2016
Q1 		$1.24M Sell
11,994
-3,993
-25% -$386K 0.05% 320
2015
Q4 		$1.59M Buy
+15,987
New +$1.56M 0.05% 291
2015
Q3 		– Sell
-104,635
Closed -$11.1M – 447
2015
Q2 		$11.1M Sell
104,635
-56,591
-35% -$6.26M 0.22% 155
2015
Q1 		$18.4M Buy
161,226
+47,926
+42% +$5.47M 0.34% 68
2014
Q4 		$12.5M Sell
113,300
-94,544
-45% -$9.97M 0.12% 166
2014
Q3 		$20.3M Buy
207,844
+7,272
+4% +$715K 0.15% 141
2014
Q2 		$20.2M Sell
200,572
-32,108
-14% -$3.13M 0.14% 161
2014
Q1 		$21.4M Buy
232,680
+24,823
+12% +$2.29M 0.16% 132
2013
Q4 		$18.8M Sell
207,857
-8,693
-4% -$752K 0.16% 142
2013
Q3 		$17.3M Buy
216,550
+6,286
+3% +$495K 0.18% 134
2013
Q2 		$15.3M Buy
+210,264
New +$15.7M 0.19% 131

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Euclid Advisors's ZBH Position: Q3 2016 in Review

Euclid Advisors sold out of Zimmer Biomet (ZBH) in Q3 2016, closing a stake of 13,519 shares — an estimated $1.58M sold.

Euclid Advisors first reported a position in ZBH in Q2 2013 and held it in 12 quarters. The position peaked at $21.4M in Q1 2014. 809 funds tracked by Wall St. Rank hold ZBH as of Q3 2016.

  • Euclid Advisors reported no remaining Zimmer Biomet position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 13,519 Zimmer Biomet shares in Q3 2016, an estimated $1.58M.
  • Euclid Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 12 quarters.
  • Euclid Advisors's Zimmer Biomet position peaked at $21.4M in Q1 2014.
  • 809 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.